Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Karuna Therapeutics Q3 EPS $(2.38) Down From $(1.72) YoY

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.
byBenzinga Newsdesk
November 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

‘Apple Set To Be First Big Tech Group To Face Charges Under EU Digital Law; Brussels To Announce iPhone Maker Is Failing To Adhere To New Rules Designed To Open Up Its App Store To Competition’ – Financial Times

By Benzinga Newsdesk
June 14, 11:34 AM
https://www.ft.com/content/31a996d5-b472-4357-953e-ace078494604Brussels is set to charge Apple over allegedly stifling competition on its mobile app store, the first time EU regulators have used new digital rules to

AAPL